US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist

0.716
-0.045-5.85%

Close May 10 16:00 ET

0.720
+0.004+0.61%

Post 17:12 ET

39.12MMarket Cap-326P/E (TTM)

Cara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-16.95%-92.08M

26.12%-17.37M

22.02%-19.65M

-354.03%-20.45M

-35.62%-34.62M

-31.03%-78.73M

-1,788.35%-23.51M

-78.46%-25.19M

78.56%-4.5M

-7.61%-25.53M

Net income from continuing operations

-38.65%-118.51M

-6.59%-32.34M

-20.93%-28.03M

-648.43%-31.48M

3.91%-26.67M

3.35%-85.47M

9.12%-30.34M

-2,188.25%-23.18M

86.32%-4.21M

-19.09%-27.75M

Depreciation and amortization

4.44%259K

34.43%82K

-3.28%59K

-4.76%60K

-7.94%58K

0.00%248K

-1.61%61K

3.28%63K

0.00%63K

Other non cash items

88.40%2.68M

297.28%1.46M

28.33%462K

9.40%384K

9.01%375K

8.88%1.42M

8.90%367K

8.76%360K

9.01%351K

8.86%344K

Change In working capital

178.67%10.17M

255.22%10.07M

177.57%4.64M

226.87%7.11M

-178.66%-11.65M

-345.56%-12.92M

-87.51%2.83M

66.98%-5.98M

-198.47%-5.6M

16.69%-4.18M

-Change in receivables

113.21%436K

-72.89%1.71M

443.79%5.51M

28.07%-3.98M

-13.15%-2.81M

-461.95%-3.3M

-68.24%6.32M

92.00%-1.6M

-301.42%-5.54M

-46.95%-2.48M

-Change in inventory

-317.91%-438K

181.20%445K

-90.52%154K

106.12%95K

-267.21%-1.13M

107.78%201K

78.79%-548K

--1.63M

---1.55M

--677K

-Change in prepaid assets

159.01%8.11M

96.25%4.5M

118.49%2.32M

343.04%2.22M

64.23%-928K

-243.85%-13.75M

-38.62%2.3M

-715.41%-12.54M

-119.33%-913K

-175.37%-2.59M

-Change in payables and accrued expense

-42.33%3.28M

167.80%3.24M

-141.49%-2.9M

226.85%9.25M

-1,087.19%-6.32M

656.76%5.68M

-333.09%-4.78M

2,089.34%6.98M

304.11%2.83M

131.98%640K

-Change in other current liabilities

-9.29%-1.92M

-40.66%-640K

23.15%-342K

-9.72%-474K

-9.22%-462K

-9.55%-1.76M

-9.38%-455K

-9.61%-445K

-9.64%-432K

-9.59%-423K

-Change in other working capital

--699K

--807K

----

Cash from discontinued investing activities

Operating cash flow

-16.95%-92.08M

26.12%-17.37M

22.02%-19.65M

-354.03%-20.45M

-35.62%-34.62M

-31.03%-78.73M

-1,788.35%-23.51M

-78.46%-25.19M

78.56%-4.5M

-7.61%-25.53M

Investing cash flow

Cash flow from continuing investing activities

-66.23%43.46M

-167.99%-30.21M

9.35%23.16M

10.53%32.8M

-47.03%17.71M

2,809.05%128.71M

182.91%44.42M

46.72%21.18M

44.57%29.68M

141.05%33.43M

Net PPE purchase and sale

-5,423.26%-2.38M

---2.05M

---323K

--0

-238.71%-43K

--0

-161.43%-43K

Net investment purchase and sale

-64.40%45.84M

-163.37%-28.15M

10.87%23.48M

10.53%32.8M

-47.10%17.71M

2,792.39%128.75M

182.97%44.42M

46.72%21.18M

44.57%29.68M

142.58%33.47M

Cash from discontinued investing activities

Investing cash flow

-66.23%43.46M

-167.99%-30.21M

9.35%23.16M

10.53%32.8M

-47.03%17.71M

2,809.05%128.71M

182.91%44.42M

46.72%21.18M

44.57%29.68M

141.05%33.43M

Financing cash flow

Cash flow from continuing financing activities

12,167.20%38.15M

165,695.45%36.48M

973.08%1.12M

18,566.67%560K

-99.33%311K

-99.95%22K

-69.32%104K

-37.88%182K

-99.56%3K

Net common stock issuance

--1.12M

--0

----

--0

----

Proceeds from stock option exercised by employees

80.06%560K

-95.45%1K

-100.96%-1K

--0

18,566.67%560K

-81.03%311K

-93.10%22K

-69.32%104K

-37.88%182K

-99.56%3K

Net other financing activities

--36.47M

----

Cash from discontinued financing activities

Financing cash flow

12,167.20%38.15M

165,695.45%36.48M

973.08%1.12M

--0

18,566.67%560K

-99.33%311K

-99.95%22K

-69.32%104K

-37.88%182K

-99.56%3K

Net cash flow

Beginning cash position

362.80%64.15M

49.91%64.78M

27.65%60.16M

119.56%47.8M

362.80%64.15M

-56.81%13.86M

84.68%43.21M

107.21%47.13M

-5.05%21.77M

-56.81%13.86M

Current changes in cash

-120.81%-10.47M

-153.02%-11.1M

218.25%4.63M

-51.26%12.36M

-306.73%-16.35M

375.85%50.29M

319.49%20.94M

-696.34%-3.91M

13,880.43%25.36M

186.31%7.91M

End cash Position

-16.32%53.68M

49.91%64.78M

27.65%60.16M

119.56%47.8M

362.80%64.15M

84.68%43.21M

107.21%47.13M

-5.05%21.77M

Free cash flow

-19.91%-94.45M

17.39%-19.42M

20.74%-19.97M

-354.03%-20.45M

-35.40%-34.62M

-31.01%-78.77M

-1,731.00%-23.51M

-78.46%-25.19M

78.56%-4.5M

-7.79%-25.57M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-16.95%-92.08M	26.12%-17.37M	22.02%-19.65M	-354.03%-20.45M	-35.62%-34.62M	-31.03%-78.73M	-1,788.35%-23.51M	-78.46%-25.19M	78.56%-4.5M	-7.61%-25.53M
Net income from continuing operations	-38.65%-118.51M	-6.59%-32.34M	-20.93%-28.03M	-648.43%-31.48M	3.91%-26.67M	3.35%-85.47M	9.12%-30.34M	-2,188.25%-23.18M	86.32%-4.21M	-19.09%-27.75M
Depreciation and amortization	4.44%259K	34.43%82K	-3.28%59K	-4.76%60K	-7.94%58K	0.00%248K	-1.61%61K	-1.61%61K	3.28%63K	0.00%63K
Other non cash items	88.40%2.68M	297.28%1.46M	28.33%462K	9.40%384K	9.01%375K	8.88%1.42M	8.90%367K	8.76%360K	9.01%351K	8.86%344K
Change In working capital	178.67%10.17M	255.22%10.07M	177.57%4.64M	226.87%7.11M	-178.66%-11.65M	-345.56%-12.92M	-87.51%2.83M	66.98%-5.98M	-198.47%-5.6M	16.69%-4.18M
-Change in receivables	113.21%436K	-72.89%1.71M	443.79%5.51M	28.07%-3.98M	-13.15%-2.81M	-461.95%-3.3M	-68.24%6.32M	92.00%-1.6M	-301.42%-5.54M	-46.95%-2.48M
-Change in inventory	-317.91%-438K	181.20%445K	-90.52%154K	106.12%95K	-267.21%-1.13M	107.78%201K	78.79%-548K	--1.63M	---1.55M	--677K
-Change in prepaid assets	159.01%8.11M	96.25%4.5M	118.49%2.32M	343.04%2.22M	64.23%-928K	-243.85%-13.75M	-38.62%2.3M	-715.41%-12.54M	-119.33%-913K	-175.37%-2.59M
-Change in payables and accrued expense	-42.33%3.28M	167.80%3.24M	-141.49%-2.9M	226.85%9.25M	-1,087.19%-6.32M	656.76%5.68M	-333.09%-4.78M	2,089.34%6.98M	304.11%2.83M	131.98%640K
-Change in other current liabilities	-9.29%-1.92M	-40.66%-640K	23.15%-342K	-9.72%-474K	-9.22%-462K	-9.55%-1.76M	-9.38%-455K	-9.61%-445K	-9.64%-432K	-9.59%-423K
-Change in other working capital	--699K	--807K	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-16.95%-92.08M	26.12%-17.37M	22.02%-19.65M	-354.03%-20.45M	-35.62%-34.62M	-31.03%-78.73M	-1,788.35%-23.51M	-78.46%-25.19M	78.56%-4.5M	-7.61%-25.53M
Investing cash flow
Cash flow from continuing investing activities	-66.23%43.46M	-167.99%-30.21M	9.35%23.16M	10.53%32.8M	-47.03%17.71M	2,809.05%128.71M	182.91%44.42M	46.72%21.18M	44.57%29.68M	141.05%33.43M
Net PPE purchase and sale	-5,423.26%-2.38M	---2.05M	---323K	--0	--0	-238.71%-43K	--0	--0	--0	-161.43%-43K
Net investment purchase and sale	-64.40%45.84M	-163.37%-28.15M	10.87%23.48M	10.53%32.8M	-47.10%17.71M	2,792.39%128.75M	182.97%44.42M	46.72%21.18M	44.57%29.68M	142.58%33.47M
Cash from discontinued investing activities
Investing cash flow	-66.23%43.46M	-167.99%-30.21M	9.35%23.16M	10.53%32.8M	-47.03%17.71M	2,809.05%128.71M	182.91%44.42M	46.72%21.18M	44.57%29.68M	141.05%33.43M
Financing cash flow
Cash flow from continuing financing activities	12,167.20%38.15M	165,695.45%36.48M	973.08%1.12M	0	18,566.67%560K	-99.33%311K	-99.95%22K	-69.32%104K	-37.88%182K	-99.56%3K
Net common stock issuance	--1.12M	--0	----	----	----	--0	--0	----	----	----
Proceeds from stock option exercised by employees	80.06%560K	-95.45%1K	-100.96%-1K	--0	18,566.67%560K	-81.03%311K	-93.10%22K	-69.32%104K	-37.88%182K	-99.56%3K
Net other financing activities	--36.47M	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	12,167.20%38.15M	165,695.45%36.48M	973.08%1.12M	--0	18,566.67%560K	-99.33%311K	-99.95%22K	-69.32%104K	-37.88%182K	-99.56%3K
Net cash flow
Beginning cash position	362.80%64.15M	49.91%64.78M	27.65%60.16M	119.56%47.8M	362.80%64.15M	-56.81%13.86M	84.68%43.21M	107.21%47.13M	-5.05%21.77M	-56.81%13.86M
Current changes in cash	-120.81%-10.47M	-153.02%-11.1M	218.25%4.63M	-51.26%12.36M	-306.73%-16.35M	375.85%50.29M	319.49%20.94M	-696.34%-3.91M	13,880.43%25.36M	186.31%7.91M
End cash Position	-16.32%53.68M	-16.32%53.68M	49.91%64.78M	27.65%60.16M	119.56%47.8M	362.80%64.15M	362.80%64.15M	84.68%43.21M	107.21%47.13M	-5.05%21.77M
Free cash flow	-19.91%-94.45M	17.39%-19.42M	20.74%-19.97M	-354.03%-20.45M	-35.40%-34.62M	-31.01%-78.77M	-1,731.00%-23.51M	-78.46%-25.19M	78.56%-4.5M	-7.79%-25.57M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall